Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mesude Falay

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|July 18, 2017
The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell LymphomaMesude Falay, Berna Afacan Öztürk, Kürşad Güneş, et al.
International Journal of Hematology-Oncology and Stem Cell Research|August 28, 2023
Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic LeukemiaAysun Şentürk Yikilmaz, Şule Mine Bakanay, Duygu Nurdan Avcı, et al.
Journal of Clinical Laboratory Analysis|February 28, 2018
What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?Mesude Falay, Mehmet Senes, Dogan Yücel, et al.
Clinical Laboratory|March 15, 2019
CD81 Expression in the Differential Diagnosis of Chronic Lymphocytic LeukemiaHacer B Afacan-Öztürk, Mesude Falay, Murat Albayrak, et al.
International Journal of Laboratory Hematology|August 21, 2018
Biological variation estimates of prothrombin time, activated partial thromboplastin time, and fibrinogen in 28 healthy individualsMesude Falay, Mehmet Senes, Selcuk Korkmaz, et al.
Revista Da Associacao Medica Brasileira (1992)|December 17, 2020
Comparative evaluation of memory T cells in COVID-19 patients and the predictive role of CD4+CD8+ double positive T lymphocytes as a new markerYasin Kalpakci, Tuba Hacibekiroglu, Gulay Trak, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 12, 2021
Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICEAhmet Kursad Gunes, Simten Dagdas, Funda Ceran, et al.
Hematology, Transfusion and Cell Therapy|February 26, 2022
A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometryZehra Narli Ozdemir, Mesude Falay, Ayhan Parmaksiz, et al.
Journal of Immunological Methods|April 26, 2019
Biological variation of peripheral blood T-lymphocytesMesude Falay, Mehmet Senes, Selçuk Korkmaz, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|May 27, 2022
Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving Time of <i>BCR::ABL1</i> IS Transcript LevelsFunda Ceran, Sema Akıncı, Mehmet Ali Uçar, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|July 18, 2017
The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell LymphomaMesude Falay, Berna Afacan Öztürk, Kürşad Güneş, et al.
International Journal of Hematology-Oncology and Stem Cell Research|August 28, 2023
Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic LeukemiaAysun Şentürk Yikilmaz, Şule Mine Bakanay, Duygu Nurdan Avcı, et al.
Journal of Clinical Laboratory Analysis|February 28, 2018
What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?Mesude Falay, Mehmet Senes, Dogan Yücel, et al.
Clinical Laboratory|March 15, 2019
CD81 Expression in the Differential Diagnosis of Chronic Lymphocytic LeukemiaHacer B Afacan-Öztürk, Mesude Falay, Murat Albayrak, et al.
International Journal of Laboratory Hematology|August 21, 2018
Biological variation estimates of prothrombin time, activated partial thromboplastin time, and fibrinogen in 28 healthy individualsMesude Falay, Mehmet Senes, Selcuk Korkmaz, et al.
Revista Da Associacao Medica Brasileira (1992)|December 17, 2020
Comparative evaluation of memory T cells in COVID-19 patients and the predictive role of CD4+CD8+ double positive T lymphocytes as a new markerYasin Kalpakci, Tuba Hacibekiroglu, Gulay Trak, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 12, 2021
Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICEAhmet Kursad Gunes, Simten Dagdas, Funda Ceran, et al.
Hematology, Transfusion and Cell Therapy|February 26, 2022
A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometryZehra Narli Ozdemir, Mesude Falay, Ayhan Parmaksiz, et al.
Journal of Immunological Methods|April 26, 2019
Biological variation of peripheral blood T-lymphocytesMesude Falay, Mehmet Senes, Selçuk Korkmaz, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|May 27, 2022
Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving Time of <i>BCR::ABL1</i> IS Transcript LevelsFunda Ceran, Sema Akıncı, Mehmet Ali Uçar, et al.
Pageof 3